MarketCap
Facebook
X
TelegramQuarterly report 2023-Q3
added 11-08-2023
Invitae Corporation P/B Ratio 2011-2026 | NVTA
Annual P/B Ratio Invitae Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.02 | 0.796 | 3.37 | 4.68 | 5.77 | 2.67 | 2.78 | 1.43 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.77 | 0.796 | 3.32 |
P/B Ratio of other stocks in the Diagnostics research industry
| Issuer | P/B Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
0.532 | - | -17.87 % | $ 25.9 M |  Canada |
|
Centogene N.V.
CNTG
|
1.47 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
7.78 | $ 114.87 | -0.65 % | $ 34.9 B |  USA |
 |
Accelerate Diagnostics
AXDX
|
-1.81 | - | -61.36 % | $ 2.46 M | USA |
 |
Aspira Women's Health
AWH
|
6.75 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
0.67 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
0.707 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-2.99 | - | - | $ 9.42 M |  Israel |
 |
Co-Diagnostics
CODX
|
0.284 | $ 1.63 | -1.21 % | $ 2.17 M | USA |
 |
Castle Biosciences
CSTL
|
1.56 | $ 24.7 | -1.12 % | $ 686 M | USA |
 |
CareDx, Inc
CDNA
|
3.28 | $ 21.91 | 0.27 % | $ 1.17 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
1.97 | - | - | $ 562 M |  Britain |
 |
DermTech
DMTK
|
0.742 | - | -11.32 % | $ 2.94 M | USA |
 |
Enzo Biochem
ENZ
|
0.00103 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
8.12 | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
0.413 | $ 15.3 | -1.92 % | $ 463 M | USA |
 |
Global Cord Blood Corporation
CO
|
0.0498 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
3.46 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
561 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
1.28 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
2.4 | $ 166.79 | -2.59 % | $ 8.27 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
5.32 | - | - | $ 10.7 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
0.554 | - | -20.0 % | $ 1.06 M | USA |
 |
Guardant Health
GH
|
-135 | $ 83.09 | -6.11 % | $ 10.4 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
0.995 | $ 27.12 | -1.53 % | $ 20 B |  Niderland |
 |
Illumina
ILMN
|
2.6 | $ 126.92 | -1.24 % | $ 20.2 B | USA |
 |
Heska Corporation
HSKA
|
2 | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
0.328 | $ 1.93 | - | $ 8.54 M | USA |
 |
Lantheus Holdings
LNTH
|
4.7 | $ 83.55 | -0.67 % | $ 5.64 B | USA |
 |
QIAGEN N.V.
QGEN
|
1.84 | - | - | $ 10.6 B | Niderland |
 |
Medpace Holdings
MEDP
|
28.2 | $ 409.65 | -2.78 % | $ 11.8 B | USA |
 |
Biomerica
BMRA
|
1.75 | $ 2.19 | 0.46 % | $ 5.03 M | USA |
 |
Motus GI Holdings
MOTS
|
0.368 | - | -34.28 % | $ 263 K | Israel |
 |
ICON Public Limited Company
ICLR
|
1.74 | $ 102.49 | -0.7 % | $ 8.45 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
2.77 | $ 259.57 | -1.47 % | $ 21.6 B | USA |
 |
NeoGenomics
NEO
|
1.77 | $ 9.02 | 4.76 % | $ 1.16 B | USA |
 |
Celcuity
CELC
|
53.4 | $ 120.07 | -4.46 % | $ 5.61 B | USA |
 |
Neogen Corporation
NEOG
|
0.492 | $ 9.34 | -1.16 % | $ 2.03 B | USA |
 |
National Research Corporation
NRC
|
22.5 | $ 16.84 | -1.58 % | $ 377 M | USA |
 |
Myriad Genetics
MYGN
|
1.11 | $ 4.84 | 0.21 % | $ 448 M | USA |
 |
Natera
NTRA
|
7.52 | $ 200.17 | -2.06 % | $ 19.7 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.44 | $ 195.05 | -0.8 % | $ 21.7 B | USA |
 |
OpGen
OPGN
|
1.24 | - | -16.95 % | $ 1.54 M | USA |
 |
Organovo Holdings
ONVO
|
0.296 | - | -2.3 % | $ 19.4 M | USA |
 |
PerkinElmer
PKI
|
1.85 | - | -0.91 % | $ 14.7 B | USA |
 |
Precipio
PRPO
|
2.63 | $ 31.75 | 3.42 % | $ 51 M | USA |
 |
Personalis
PSNL
|
1.25 | $ 5.5 | -7.72 % | $ 326 M | USA |
 |
Senseonics Holdings
SENS
|
5.74 | $ 7.18 | -1.24 % | $ 300 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
1.22 | $ 16.65 | -12.64 % | $ 179 M | China |